mesalamine has been researched along with Diabetic Nephropathies in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oshimoto, H | 1 |
| Okamura, S | 1 |
| Onozato, Y | 1 |
| Ishihara, H | 1 |
| Mori, M | 1 |
1 other study available for mesalamine and Diabetic Nephropathies
| Article | Year |
|---|---|
Mesalazine for ulcerative colitis complicated with diabetic nephropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diabetic Nephropathies; Female; Humans | 2001 |